< Back to previous page

Publication

Efficacy/safety Of Ocrelizumab In Relapsing-remitting MS Patients With Suboptimal Response To Prior Disease-modifying Therapies (1-yr Interim Results)

Journal Contribution - Journal Abstract Conference Contribution

Journal: MULTIPLE SCLEROSIS JOURNAL

ISSN: 1477-0970

Issue: 1_SUPPL

Volume: 26

Pages: 32 - 32

Publication year:2020

WoS Id: 000532412600068
Handle: http://hdl.handle.net/1942/31461

Accessibility:Closed